Our foundation covers all products, including generic or bioequivalent drugs, as prescribed by the patient’s treating physician to treat his/her primary cancer diagnosis as long as the medication has been approved by the Food and Drug Administration (FDA), is classified as a chemotherapy or targeted treatment drug,  NCCN Compendia Recommended and covered by the patient’s primary insurance provider.

If you are not sure if your medication is covered, please contact us

Powered by Patients&Pros on DiseaseTrak Technologies